Oral Dosage Form New Animal Drugs; Chlortetracycline Powder, 62490-62491 [E9-28468]
Download as PDF
62490
Federal Register / Vol. 74, No. 228 / Monday, November 30, 2009 / Rules and Regulations
Examining the AD Docket
You may examine the AD docket on
the Internet at https://
www.regulations.gov; or in person at the
Docket Management Facility between 9
a.m. and 5 p.m., Monday through
Friday, except Federal holidays. The AD
docket contains the NPRM, the
regulatory evaluation, any comments
received, and other information. The
street address for the Docket Office
(telephone (800) 647–5527) is in the
ADDRESSES section. Comments will be
available in the AD docket shortly after
receipt.
List of Subjects in 14 CFR Part 39
Air transportation, Aircraft, Aviation
safety, Incorporation by reference,
Safety.
Adoption of the Amendment
Accordingly, under the authority
delegated to me by the Administrator,
the FAA amends 14 CFR part 39 as
follows:
■
PART 39—AIRWORTHINESS
DIRECTIVES
1. The authority citation for part 39
continues to read as follows:
■
Authority: 49 U.S.C. 106(g), 40113, 44701.
§ 39.13
[Amended]
2. The FAA amends § 39.13 by adding
the following new AD:
■
2009–24–14 Empresa Brasileira de
´
Aeronautica S.A. (EMBRAER):
Amendment 39–16108; Docket No.
FAA–2009–0870; Directorate Identifier
2009–CE–049–AD.
Effective Date
(a) This airworthiness directive (AD)
becomes effective January 4, 2010.
Affected ADs
(b) None.
Applicability
(c) This AD applies to EMB–500 airplanes,
serial numbers 50000005, 50000006,
50000008 through 50000036, 50000038
through 50000041, 50000043 through
50000046, 50000048, and 50000053,
certificated in any category.
WReier-Aviles on DSKGBLS3C1PROD with RULES
Subject
(d) Air Transport Association of America
(ATA) Code 27: Flight Controls.
Reason
(e) The mandatory continuing
airworthiness information (MCAI) states:
It has been found the possibility of elevator
mass balance fasteners becoming slack under
certain conditions. The loose of at least two
fasteners may lead to an unbalance
condition, which may induce flutter on
airplane elevators.
VerDate Nov<24>2008
14:56 Nov 27, 2009
Jkt 220001
The MCAI requires replacement of the nuts
of the right and left elevators mass balance
fasteners.
Actions and Compliance
(f) Unless already done, do the following
actions:
(1) Within the next 30 days after January
4, 2010 (the effective date of this AD), replace
the nuts of the right-hand (RH) and left-hand
(LH) elevators’ mass balance fasteners with
new ones of self-locking type bearing part
number (P/N) MS21043–4. Do the
replacements following Phenom by Embraer
Service Bulletin No. 500–55–0001, dated July
24, 2009.
(2) As of 30 days after January 4, 2010 (the
effective date of this AD), only install selflocking type nuts, P/N MS21043–4, on the
RH and LH elevators’ mass balance fasteners.
FAA AD Differences
Note: This AD differs from the MCAI and/
or service information as follows: No
differences.
Other FAA AD Provisions
(g) The following provisions also apply to
this AD:
(1) Alternative Methods of Compliance
(AMOCs): The Manager, Standards Office,
FAA, has the authority to approve AMOCs
for this AD, if requested using the procedures
found in 14 CFR 39.19. Send information to
Attn: Karl Schletzbaum, Aerospace Engineer,
FAA, Small Airplane Directorate, 901 Locust,
Room 301, Kansas City, Missouri 64106;
telephone: (816) 329–4146; fax: (816) 329–
4090. Before using any approved AMOC on
any airplane to which the AMOC applies,
notify your appropriate principal inspector
(PI) in the FAA Flight Standards District
Office (FSDO), or lacking a PI, your local
FSDO.
(2) Airworthy Product: For any requirement
in this AD to obtain corrective actions from
a manufacturer or other source, use these
actions if they are FAA-approved. Corrective
actions are considered FAA-approved if they
are approved by the State of Design Authority
(or their delegated agent). You are required
to assure the product is airworthy before it
is returned to service.
(3) Reporting Requirements: For any
reporting requirement in this AD, under the
provisions of the Paperwork Reduction Act
(44 U.S.C. 3501 et seq.), the Office of
Management and Budget (OMB) has
approved the information collection
requirements and has assigned OMB Control
Number 2120–0056.
Related Information
ˆ
(h) Refer to MCAI Agencia Nacional de
Aviacao Civil (ANAC) Brazilian
¸˜
Airworthiness Directive AD No.: 2009–09–
01, dated September 3, 2009, and Phenom by
Embraer Service Bulletin No. 500–55–0001,
dated July 24, 2009, for related information.
Material Incorporated by Reference
(i) You must use Phenom by Embraer
Service Bulletin No. 500–55–0001, dated July
24, 2009, to do the actions required by this
AD, unless the AD specifies otherwise.
(1) The Director of the Federal Register
approved the incorporation by reference of
PO 00000
Frm 00018
Fmt 4700
Sfmt 4700
this service information under 5 U.S.C.
552(a) and 1 CFR part 51.
(2) For service information identified in
this AD, contact EMBRAER Empresa
´
Brasileira de Aeronautica S.A., Phenom
Maintenance Support, Av. Brig. Farina Lima,
2170, Sao Jose dos Campos—SP, CEP: 12227–
901—PO Box: 38/2, BRASIL, telephone: ++55
12 3927–5383; fax: ++55 12 3927–2610; Email: reliability.executive@embraer.com.br;
Internet: https://www.embraer.com.br.
(3) You may review copies of the service
information incorporated by reference for
this AD at the FAA, Central Region, Office of
the Regional Counsel, 901 Locust, Kansas
City, Missouri 64106. For information on the
availability of this material at the Central
Region, call (816) 329–3768.
(4) You may also review copies of the
service information incorporated by reference
for this AD at the National Archives and
Records Administration (NARA). For
information on the availability of this
material at NARA, call (202) 741–6030, or go
to: https://www.archives.gov/federal_register/
code_of_federal_regulations/ibr_
locations.html.
Issued in Kansas City, Missouri, on
November 19, 2009.
Patrick R. Mullen,
Acting Manager, Small Airplane Directorate,
Aircraft Certification Service.
[FR Doc. E9–28306 Filed 11–27–09; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 520
[Docket No. FDA–2009–N–0665]
Oral Dosage Form New Animal Drugs;
Chlortetracycline Powder
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Final rule.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect
approval of an abbreviated new animal
drug application (ANADA) filed by
Alpharma Inc. The ANADA provides for
use of generic chlortetracycline soluble
powder to make medicated drinking
water for cattle, swine, chickens, and
turkeys for the treatment of several
bacterial diseases.
DATES: This rule is effective November
30, 2009.
FOR FURTHER INFORMATION CONTACT: John
K. Harshman, Center for Veterinary
Medicine (HFV–104), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 240–276–8197, email: john.harshman@fda.hhs.gov.
E:\FR\FM\30NOR1.SGM
30NOR1
Federal Register / Vol. 74, No. 228 / Monday, November 30, 2009 / Rules and Regulations
Alpharma
Inc., 440 Route 22, Bridgewater, NJ
08807, filed ANADA 200–441 that
provides for the use of A–MYCIN
(chlortetracycline) Soluble Powder to
make medicated drinking water for
cattle, swine, chickens, and turkeys for
the treatment of several bacterial
diseases. Alpharma Inc.’s A–MYCIN
Soluble Powder is approved as a generic
copy of Fort Dodge Animal Health, A
Division of Wyeth Holdings Corp.’s
AUREOMYCIN (chlortetracycline)
Soluble Powder, approved under NADA
65–440. The ANADA is approved as of
October 9, 2009, and the regulations are
amended in 21 CFR 520.445b to reflect
the approval.
In accordance with the freedom of
information provisions of 21 CFR part
20 and 21 CFR 514.11(e)(2)(ii), a
summary of safety and effectiveness
data and information submitted to
support approval of this application
may be seen in the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852, between 9
a.m. and 4 p.m., Monday through
Friday.
FDA has determined under 21 CFR
25.33 that this action is of a type that
does not individually or cumulatively
have a significant effect on the human
environment. Therefore, neither an
environmental assessment nor an
environmental impact statement is
required.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
SUPPLEMENTARY INFORMATION:
List of Subjects in 21 CFR Part 520
Animal drugs.
■ Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 520 is amended as follows:
PART 520—ORAL DOSAGE FORM
NEW ANIMAL DRUGS
1. The authority citation for 21 CFR
part 520 continues to read as follows:
■
WReier-Aviles on DSKGBLS3C1PROD with RULES
Authority: 21 U.S.C. 360b.
2. In § 520.445b, revise paragraph
(b)(2) to read as follows:
■
§ 520.445b
Chlortetracycline powder.
*
*
*
*
*
(b) * * *
(2) Nos. 046573 and 053501 for use as
in paragraph (d) of this section.
*
*
*
*
*
VerDate Nov<24>2008
14:56 Nov 27, 2009
Jkt 220001
Dated: November 23, 2009.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. E9–28468 Filed 11–27–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
33 CFR Part 165
[Docket No. USCG–2009–0985]
RIN 1625–AA00
Safety Zone; Atlantic Intracoastal
Waterway, Sunset Beach, NC
Coast Guard, DHS.
Temporary final rule.
AGENCY:
ACTION:
SUMMARY: The Coast Guard is
establishing a temporary safety zone on
the waters of the Atlantic Intracoastal
Waterway at Sunset Beach, North
Carolina. The safety zone is necessary to
provide for the safety of mariners on
navigable waters during the installation
of bridge girders at the new high-level
fixed highway bridge at Sunset Beach,
North Carolina.
DATES: This rule will be in effect from
6 a.m. on December 1, 2009 through 6
p.m. on January 31, 2010.
ADDRESSES: Documents indicated in this
preamble as being available in the
docket are part of docket USCG–2009–
0985 and are available online by going
to https://www.regulations.gov, inserting
USCG–2009–0985 in the ‘‘Keyword’’
box, and then clicking ‘‘Search.’’ They
are also available for inspection or
copying at the Docket Management
Facility (M–30), U.S. Department of
Transportation, West Building Ground
Floor, Room W12–140, 1200 New Jersey
Avenue, SE., Washington, DC 20590,
between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
FOR FURTHER INFORMATION CONTACT: If
you have questions on this temporary
rule, call or e-mail CWO4 Stephen
Lyons, Waterways Management
Division Chief, Coast Guard Sector
North Carolina; telephone (252) 247–
4525, e-mail
Stephen.W.Lyons2@uscg.mil. If you
have questions on viewing the docket,
call Renee V. Wright, Program Manager,
Docket Operations, telephone 202–366–
9826.
SUPPLEMENTARY INFORMATION:
Regulatory Information
The Coast Guard is issuing this
temporary final rule without prior
PO 00000
Frm 00019
Fmt 4700
Sfmt 4700
62491
notice and opportunity to comment
pursuant to authority under section 4(a)
of the Administrative Procedure Act
(APA) (5 U.S.C. 553(b)). This provision
authorizes an agency to issue a rule
without prior notice and opportunity to
comment when the agency for good
cause finds that those procedures are
‘‘impracticable, unnecessary, or contrary
to the public interest.’’ Under 5 U.S.C.
553(b)(B), the Coast Guard finds that
good cause exists for not publishing a
notice of proposed rulemaking (NPRM)
with respect to this rule because it is in
the public interest to have this
regulation in place during the girder
installation due to the hazards
associated with potential falling debris
and the use of heavy equipment and
machinery in the waterway.
Under 5 U.S.C. 553(d)(3), the Coast
Guard finds that good cause exists for
making this rule effective less than 30
days after publication in the Federal
Register. Delaying the effective date
would be contrary to public interest,
since immediate action is needed to
ensure the public’s safety from the
hazards noted above.
Background and Purpose
The State of North Carolina
Department of Transportation awarded a
contract to English Construction
Company Inc. of Lynchburg, Virginia to
perform bridge girder installation at the
new high-level fixed highway bridge at
Sunset Beach, North Carolina. The
contract provides for the installation of
bridge girders. The center bridge girder
installation is scheduled daily from 6
a.m. on December 1, 2009 through 6
p.m. on January 31, 2010. The
contractor will be utilizing a deck barge
with a 50′ beam, a ringer crane on a
stationary barge with an 85′ beam, and
an assist tug to conduct the girder
installation. This operation presents a
potential hazard to mariners from falling
debris and the use of heavy equipment
and machinery. To provide for the
safety of the public, the Coast Guard
will temporarily restrict access to this
section of the Atlantic Intracoastal
Waterway during girder installation,
scheduled daily from 6 a.m. until 6 p.m.
Discussion of Rule
The Coast Guard is establishing a
temporary safety zone to encompass the
waters of the Atlantic Intracoastal
Waterway extending 250 yards in all
directions from the main construction
site. All vessels are prohibited from
transiting this section of the waterway
while the safety zone is in effect. Entry
into the zone will not be permitted
except as specifically authorized by the
Captain of the Port or a designated
E:\FR\FM\30NOR1.SGM
30NOR1
Agencies
[Federal Register Volume 74, Number 228 (Monday, November 30, 2009)]
[Rules and Regulations]
[Pages 62490-62491]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-28468]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 520
[Docket No. FDA-2009-N-0665]
Oral Dosage Form New Animal Drugs; Chlortetracycline Powder
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of an abbreviated new animal drug
application (ANADA) filed by Alpharma Inc. The ANADA provides for use
of generic chlortetracycline soluble powder to make medicated drinking
water for cattle, swine, chickens, and turkeys for the treatment of
several bacterial diseases.
DATES: This rule is effective November 30, 2009.
FOR FURTHER INFORMATION CONTACT: John K. Harshman, Center for
Veterinary Medicine (HFV-104), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 240-276-8197, e-mail:
john.harshman@fda.hhs.gov.
[[Page 62491]]
SUPPLEMENTARY INFORMATION: Alpharma Inc., 440 Route 22, Bridgewater, NJ
08807, filed ANADA 200-441 that provides for the use of A-MYCIN
(chlortetracycline) Soluble Powder to make medicated drinking water for
cattle, swine, chickens, and turkeys for the treatment of several
bacterial diseases. Alpharma Inc.'s A-MYCIN Soluble Powder is approved
as a generic copy of Fort Dodge Animal Health, A Division of Wyeth
Holdings Corp.'s AUREOMYCIN (chlortetracycline) Soluble Powder,
approved under NADA 65-440. The ANADA is approved as of October 9,
2009, and the regulations are amended in 21 CFR 520.445b to reflect the
approval.
In accordance with the freedom of information provisions of 21 CFR
part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and
effectiveness data and information submitted to support approval of
this application may be seen in the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
FDA has determined under 21 CFR 25.33 that this action is of a type
that does not individually or cumulatively have a significant effect on
the human environment. Therefore, neither an environmental assessment
nor an environmental impact statement is required.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 520
Animal drugs.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is
amended as follows:
PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
0
1. The authority citation for 21 CFR part 520 continues to read as
follows:
Authority: 21 U.S.C. 360b.
0
2. In Sec. 520.445b, revise paragraph (b)(2) to read as follows:
Sec. 520.445b Chlortetracycline powder.
* * * * *
(b) * * *
(2) Nos. 046573 and 053501 for use as in paragraph (d) of this
section.
* * * * *
Dated: November 23, 2009.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. E9-28468 Filed 11-27-09; 8:45 am]
BILLING CODE 4160-01-S